关注
Hengrui Zhu
Hengrui Zhu
The Wistar Institute/ Janssen R & D, China.
在 wistar.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression
H Zhu, F Bengsch, N Svoronos, MR Rutkowski, BG Bitler, MJ Allegrezza, ...
Cell reports 16 (11), 2829-2837, 2016
4042016
BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer
S Karakashev, H Zhu, Y Yokoyama, B Zhao, N Fatkhutdinov, ...
Cell reports 21 (12), 3398-3405, 2017
1772017
SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cells
TL Stephen, KK Payne, RA Chaurio, MJ Allegrezza, H Zhu, J Perez-Sanz, ...
Immunity 46 (1), 51-64, 2017
1532017
BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer
Y Yokoyama, H Zhu, JH Lee, AV Kossenkov, SY Wu, JM Wickramasinghe, ...
Cancer research 76 (21), 6320-6330, 2016
1532016
N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance
T Fukumoto, H Zhu, T Nacarelli, S Karakashev, N Fatkhutdinov, S Wu, ...
Cancer research 79 (11), 2812-2820, 2019
1502019
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
S Karakashev, H Zhu, S Wu, Y Yokoyama, BG Bitler, PH Park, JH Lee, ...
Nature communications 9 (1), 631, 2018
902018
In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor
F Xie, H Zhu, H Zhang, Q Lang, L Tang, Q Huang, L Yu
European Journal of Medicinal Chemistry 89, 310-319, 2015
812015
SPOP E3 ubiquitin ligase adaptor promotes cellular senescence by degrading the SENP7 deSUMOylase
H Zhu, S Ren, BG Bitler, KM Aird, Z Tu, E Skordalakes, Y Zhu, J Yan, ...
Cell reports 13 (6), 1183-1193, 2015
802015
Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9
M Zhang, C Dai, H Zhu, S Chen, Y Wu, Q Li, X Zeng, W Wang, J Zuo, ...
Molecular and cellular biochemistry 357, 387-395, 2011
662011
Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells
H Zhu, Z Liu, L Tang, J Liu, M Zhou, F Xie, Z Wang, Y Wang, S Shen, L Hu, ...
European journal of pharmacology 696 (1-3), 43-53, 2012
592012
Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway
L Tang, H Zhu, X Yang, F Xie, J Peng, D Jiang, J Xie, M Qi, L Yu
PLoS One 11 (3), e0152012, 2016
342016
Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts
F Bengsch, Z Tu, HY Tang, H Zhu, DW Speicher, R Zhang
Cell Cycle 14 (10), 1540-1547, 2015
272015
A novel role for the condensin II complex in cellular senescence
Y Yokoyama, H Zhu, R Zhang, K Noma
Cell Cycle 14 (13), 2160-2170, 2015
252015
Interaction of Sedlin with PAM14
X Liu, Y Wang, H Zhu, Q Zhang, X Xing, B Wu, L Song, L Fan
Journal of cellular biochemistry 109 (6), 1129-1133, 2010
142010
Pyramidatine (Z88) sensitizes vincristine-resistant human oral cancer (KB/VCR) cells to chemotherapeutic agents by inhibition of P-glycoprotein
Z Liu, H Zhu, S Qu, L Tang, L Cao, W Yu, X Yang, S Jiang, D Zhu, C Tan, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018
42018
The N6-methylation of adenosine (M6a) in Fzd10 mRNA contributes to resistance to parp Inhibitor
T Fukumoto, H Zhu, S Karakashev, T Nacarelli, N Fatkhutdinov, S Wu, ...
Clinical Cancer Research 25 (22), 204-204, 2019
32019
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. Cell Rep. 2016; 16: 2829-37
H Zhu, F Bengsch, N Svoronos, MR Rutkowski, BG Bitler, MJ Allegrezza, ...
3
Beyond immune suppression: the intrinsic function of PD-L1 in ovarian cancer and melanoma
H Zhu, R Zhang
Translational Cancer Research 6 (Suppl 1), 2017
12017
Detection of the ubiquitinome in cells undergoing oncogene-induced senescence
H Zhu, L Le, HY Tang, DW Speicher, R Zhang
Oncogene-Induced Senescence: Methods and Protocols, 127-137, 2017
12017
Abstract NT-093: THE N6-METHYLATION OF ADENOSINE (M6A) IN FZD10 MRNA CONTRIBUTES TO RESISTANCE TO PARP INHIBITOR
T Fukumoto, H Zhu, S Karakashev, T Nacarelli, N Fatkhutdinov, S Wu, ...
Clinical Cancer Research 25 (22_Supplement), NT-093-NT-093, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20